United States Federal Circuit
Antares Pharma v. Medac Pharma, 14-1648
In this patent infringement action involving defendant's alleged infringement of plaintiff's reissue patent RE44,846, which describes a system for jet-injecting medicant into the skin of a patient, the denial of plaintiff's motion for preliminary injunction is affirmed, where the reissue claims are invalid for failure to comply with the "original patent" requirement of 35 U.S.C. section 251.
Appellate Information
- Decided 11/17/2014
- Published 11/17/2014
Judges
- Dyk
Court
- United States Federal Circuit